Results 41 to 50 of about 131,342 (265)

Characteristics and management of thrombotic microangiopathy in kidney transplantation

open access: yesKorean Journal of Transplantation, 2023
Thrombotic microangiopathy is not a rare complication of kidney transplantation and is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury with extensive thrombosis of the arterioles and capillaries.
Wonyong Cho   +3 more
doaj   +1 more source

Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review

open access: yesCanadian Journal of Kidney Health and Disease, 2021
Purpose of review: Thrombotic microangiopathy (TMA) is suspected in patients presenting with thrombocytopenia and evidence of a microangiopathic hemolytic anemia.
P. McFarlane   +10 more
semanticscholar   +1 more source

Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice [PDF]

open access: yes, 2019
Atypical hemolytic uremic syndrome (aHUS) is frequently associated in humans with loss-of-function mutations in complement-regulating proteins or gain-of-function mutations in complement-activating proteins.
Atkinson, John P   +11 more
core   +3 more sources

Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget’s Disease: An Autopsy Case Report and Literature Review

open access: yesCase Reports in Oncology, 2021
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer.
Akihiro Kato   +6 more
doaj   +1 more source

Pathologic manifestations of levamisole-adulterated cocaine exposure. [PDF]

open access: yes, 2015
UnlabelledRheumatic manifestations of cocaine have been well described, but more recently, a dramatic increase in the levamisole-adulterated cocaine supply in the United States has disclosed unique pathologic consequences that are distinct from pure ...
Jen, Kuang-Yu, Nolan, Amber L
core   +1 more source

Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate > 60 mL/min at 1 year [PDF]

open access: yes, 2017
Background. Severe acute kidney injury (AKI) among hospitalized patients often necessitates initiation of short-term dialysis. Little is known about the long-term outcome of those who recover to normal renal function.
Geddes, Colin C.   +4 more
core   +1 more source

Malignant hypertension-associated thrombotic microangiopathy following cocaine use

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2016
Cocaine is one of the most commonly used illicit drugs with distribution and consumption throughout the world. Acute renal failure associated with rhabdomyolysis, direct vasoconstriction and hemodynamic alteration is well described in patients with ...
Rais Lamia   +9 more
doaj   +1 more source

Transplant-associated thrombotic microangiopathy

open access: yesPediatria Polska, 2021
Transplant-associated thrombotic microangiopathy (TA-TMA), which is a severe and quite frequent complication of hematopoietic stem cell transplantation (HSCT) in children, significantly influences patients’ overall survival.
Tomasz Jarmoliński
doaj   +1 more source

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.

open access: yesBlood, 2020
Pregnancy and postpartum are high-risk periods for different forms of thrombotic microangiopathy (TMA). However, the management of pregnancy-associated TMA remains ill-defined.
F. Fakhouri   +21 more
semanticscholar   +1 more source

Eculizumab for Gemcitabine-Induced Hemolytic Uremic Syndrome: A Novel Therapy for an Emerging Condition [PDF]

open access: yes, 2015
Introduction Atypical hemolytic uremic syndrome (aHUS), a thrombotic microangiopathy (TMA), is a disease characterized by hemolytic anemia, thrombocytopenia, and renal impairment. Gemcitabine, a commonly used chemotherapy, is emerging as a cause of aHUS.
Karkowsky, MD, Raphael   +1 more
core   +2 more sources

Home - About - Disclaimer - Privacy